NCT01842516View on ClinicalTrials.gov

Multiple Ascending Dose Study for LCB01-0371

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

LCB01-0371 800mg

LCB0-0371 800mg

DRUG

LCB01-0371 1200mg

LCB01-0371 1200mg

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

LigaChem Biosciences, Inc.

INDUSTRY

NCT01842516 - Multiple Ascending Dose Study for LCB01-0371 | Biotech Hunter | Biotech Hunter